Home-Based Long-Acting Antiretroviral Treatment Offers Safe and Effective HIV Management
Recent research has demonstrated that long-acting injectable antiretroviral therapy (ART) can be administered safely and effectively in a home setting for individuals living with HIV. A study conducted by MUSC Health Infectious Diseases expert Dr. Eric Meissner, published in Clinical Infectious Diseases, found that patients receiving ART injections at home reported high satisfaction levels, comparable to those receiving treatment in clinical settings. The study involved 33 participants choosing between clinic and home administration, with most maintaining their original choice over 12 months. All participants achieved viral suppression, and no serious safety concerns arose in either group.
Typically, long-acting injectable ART given at intervals of two months has been administered exclusively in clinics. However, the study explored the feasibility of at-home treatment, which could significantly improve adherence for patients facing challenges with daily pills or transportation logistics. Dr. Meissner, an associate professor at the Medical University of South Carolina, highlighted that convenience was the primary factor influencing patients’ treatment location choices.
In the study, medications were mailed to patients’ homes, stored in refrigerators, and administered by licensed practical nurses (LPNs). Participants appreciated the consistency of care and the ease of receiving treatment at home. Despite logistical hurdles—such as insurance reimbursement for at-home treatment—the findings suggest that expanding access to home-based injections could enhance adherence and overall health outcomes for many individuals living with HIV.
While current regulations and reimbursement policies pose challenges, the encouraging results support continued efforts to integrate home-based injectable HIV treatment into routine care, offering a safe, feasible, and satisfying option for patients. The study underscores the importance of providing more flexible treatment choices to improve adherence, health outcomes, and quality of life for those managing HIV.
Source: https://medicalxpress.com/news/2025-04-persons-hiv-safely-effectively-antiretroviral.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Childhood Exposure to Air Pollution May Impact Adolescent Health
New research reveals that childhood exposure to air pollution is linked to poorer health outcomes in late adolescence, highlighting environmental health disparities and the importance of pollution reduction policies.
Innovative Combined Therapy Using Chinese Herb Astragalus and Methotrexate Targets Drug Resistance in Autoimmune Diseases
A novel therapy combining Chinese herb Astragalus and methotrexate offers a new approach to overcoming drug resistance in autoimmune diseases, improving safety and effectiveness.
Cutting-Edge Imaging Techniques Show How Cancer Cells Respond to Multiple Drugs Simultaneously
Innovative imaging technologies enable scientists to observe how cancer cells respond to multiple drugs simultaneously, paving the way for personalized cancer therapies and improved patient outcomes.
Updated Beers Criteria Introduces Safer Medication Alternatives for Older Adults
The American Geriatrics Society introduces a new guide with safer medication alternatives to improve prescribing practices for older adults, enhancing patient safety and health outcomes.